Cargando…

Predictors of Long COVID in Patients without Comorbidities: Data from the Polish Long-COVID Cardiovascular (PoLoCOV-CVD) Study

Background: The SARS-CoV-2 pandemic has become an enormous worldwide challenge over the last two years. However, little is still known about the risk of Long COVID (LC) in patients without comorbidities. Thus, we aimed to assess the predictors of LC in patients without comorbidities. Methods: Patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chudzik, Michał, Lewek, Joanna, Kapusta, Joanna, Banach, Maciej, Jankowski, Piotr, Bielecka-Dabrowa, Agata
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456773/ https://www.ncbi.nlm.nih.gov/pubmed/36078910 http://dx.doi.org/10.3390/jcm11174980

Ejemplares similares

Long-COVID Clinical Features and Risk Factors: A Retrospective Analysis of Patients from the STOP-COVID Registry of the PoLoCOV Study
por: Chudzik, Michał, et al.
Publicado: (2022)

Persisting Smell and Taste Disorders in Patients Who Recovered from SARS-CoV-2 Virus Infection—Data from the Polish PoLoCOV-CVD Study
por: Chudzik, Michał, et al.
Publicado: (2022)

Do selected lifestyle parameters affect the severity and symptoms of COVID-19 among elderly patients? The retrospective evaluation of individuals from the STOP-COVID registry of the PoLoCOV study
por: Kapusta, Joanna, et al.
Publicado: (2023)

Do the Successive Waves of SARS-CoV-2, Vaccination Status and Place of Infection Influence the Clinical Picture and COVID-19 Severity among Patients with Persistent Clinical Symptoms? The Retrospective Study of Patients from the STOP-COVID Registry of the PoLoCOV-Study
por: Chudzik, Michał, et al.
Publicado: (2022)

Effects of Implementing Personalized Health Education in Ambulatory Care on Cardiovascular Risk Factors, Compliance and Satisfaction with Treatment
por: Bielecka-Dabrowa, Agata, et al.
Publicado: (2022)

Patient after correction Taussig‐Bing anomaly with severe neo‐aortic regurgitation after sudden cardiac arrest
por: Bielecka‐Dabrowa, Agata, et al.
Publicado: (2021)

Lifestyle, course of COVID-19, and risk of Long-COVID in non-hospitalized patients
por: Pływaczewska-Jakubowska, Magdalena, et al.
Publicado: (2022)

Diagnostic Usefulness of Spiroergometry and Risk Factors of Long COVID in Patients with Normal Left Ventricular Ejection Fraction
por: Gryglewska-Wawrzak, Katarzyna, et al.
Publicado: (2023)

Intensive Statin Therapy Versus Upfront Combination Therapy of Statin and Ezetimibe in Patients With Acute Coronary Syndrome: A Propensity Score Matching Analysis Based on the PL‐ACS Data
por: Lewek, Joanna, et al.
Publicado: (2023)

COVID-19 and cardiovascular complications – preliminary results of the LATE-COVID study
por: Lewek, Joanna, et al.
Publicado: (2021)

Factors of Persistent Limited Exercise Tolerance in Patients after COVID-19 with Normal Left Ventricular Ejection Fraction
por: Gryglewska-Wawrzak, Katarzyna, et al.
Publicado: (2022)

The Role of Multidisciplinary Approaches in the Treatment of Patients with Heart Failure and Coagulopathy of COVID-19
por: Gryglewska-Wawrzak, Katarzyna, et al.
Publicado: (2023)

The prevalence of symptoms and its correlation with sex in polish COVID-19 adult patients: Cross-sectional online open survey
por: Lewek, Pawel, et al.
Publicado: (2023)

The outcomes of hypertension treatment depending on gender in patients over 40 years of age
por: Paduszyńska, Aleksandra, et al.
Publicado: (2021)

Cardioprotective properties of leptin in patients with excessive body mass
por: Paduszyńska, Aleksandra, et al.
Publicado: (2020)

Malignancy-Associated Dyslipidemia
por: Bielecka-Dąbrowa, Agata, et al.
Publicado: (2011)

The Rise and Fall of Hypertension: Lessons Learned from Eastern Europe
por: Bielecka-Dabrowa, Agata, et al.
Publicado: (2011)

Role of confirmed and potential predictors of an unfavorable outcome in heart failure in everyday clinical practice
por: Chuda, Anna, et al.
Publicado: (2021)

Heart Failure Risk Predictions and Prognostic Factors in Adults With Congenital Heart Diseases
por: Leczycki, Patryk, et al.
Publicado: (2022)

COVID-19 and lipids. The role of lipid disorders and statin use in the prognosis of patients with SARS-CoV-2 infection
por: Surma, Stanisław, et al.
Publicado: (2021)

Endocardial Lead Extraction in the Polish Registry – clinical practice versus current Heart Rhythm Society consensus
por: Chudzik, Michał, et al.
Publicado: (2013)

Biochemical and cardiovascular predictors of PIMS-TS risk in children after COVID-19 recovery: preliminary results of the LATE-COVID-Kids Study
por: Jatczak-Pawlik, Izabela, et al.
Publicado: (2022)

The mechanisms of atrial fibrillation in hyperthyroidism
por: Bielecka-Dabrowa, Agata, et al.
Publicado: (2009)

Arterial Stiffness and Indices of Left Ventricular Diastolic Dysfunction in Patients with Embolic Stroke of Undetermined Etiology
por: Gąsiorek, Paulina, et al.
Publicado: (2019)

Adjuvant breast cancer treatments cardiotoxicity and modern methods of detection and prevention of cardiac complications
por: Bikiewicz, Agata, et al.
Publicado: (2021)

Use of 1-MNA to Improve Exercise Tolerance and Fatigue in Patients after COVID-19
por: Chudzik, Michał, et al.
Publicado: (2022)

The Relationship of Dehydration and Body Mass Index With the Occurrence of Atrial Fibrillation in Heart Failure Patients
por: Chuda, Anna, et al.
Publicado: (2021)

Menopause and women’s cardiovascular health: is it really an obvious relationship?
por: Ryczkowska, Kamila, et al.
Publicado: (2022)

Left Ventricular Diastolic Dysfunction as Predictor of Unfavorable Prognosis After ESUS
por: Bielecka-Dabrowa, Agata, et al.
Publicado: (2021)

Obesity and Body Mass Components Influence Exercise Tolerance and the Course of Hypertension in Perimenopausal Women
por: Bielecka-Dabrowa, Agata, et al.
Publicado: (2022)

Do COVID-19 Vaccinations Affect the Most Common Post-COVID Symptoms? Initial Data from the STOP-COVID Register–12-Month Follow-Up
por: Babicki, Mateusz, et al.
Publicado: (2023)

Possible Benefits of Zinc supplement in CVD and COVID-19 Comorbidity
por: Karim, Muhammad Manjurul, et al.
Publicado: (2021)

The profile of selected single nucleotide polymorphisms in patients with hypertension and heart failure with preserved and mid-range ejection fraction
por: Bielecka-Dabrowa, Agata, et al.
Publicado: (2017)

Factors and Prognostic Significance of Impaired Exercise Tolerance in Women over 40 with Arterial Hypertension
por: Bielecka-Dabrowa, Agata, et al.
Publicado: (2021)

The influence of atorvastatin on parameters of inflammation left ventricular function, hospitalizations and mortality in patients with dilated cardiomyopathy – 5-year follow-up
por: Bielecka-Dabrowa, Agata, et al.
Publicado: (2013)

The Multi-Biomarker Approach for Heart Failure in Patients with Hypertension
por: Bielecka-Dabrowa, Agata, et al.
Publicado: (2015)

Efficacy and safety of sacubitril/valsartan in heart failure compared to renin–angiotensin–aldosterone system inhibitors: a systematic review and meta-analysis of randomised controlled trials
por: Hernandez, Adrian V., et al.
Publicado: (2023)

2020 Guidelines of the Polish Society of Laboratory Diagnostics (PSLD) and the Polish Lipid Association (PoLA) on laboratory diagnostics of lipid metabolism disorders
por: Solnica, Bogdan, et al.
Publicado: (2020)

Influence of co-existing atrial fibrillation on the efficacy of atorvastatin treatment in patients with dilated cardiomyopathy: a pilot study
por: Bielecka-Dąbrowa, Agata, et al.
Publicado: (2010)

Biomarkers, myocardial fibrosis and co-morbidities in heart failure with preserved ejection fraction: an overview
por: Michalska-Kasiczak, Marta, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3j96eig17obum504lgdd319qco